✦ LIBER ✦

The Second Prevention of Syncope Trial (POST II)—a randomized clinical trial of fludrocortisone for the prevention of neurally mediated syncope: Rationale and study design

✍ Scribed by Satish R. Raj; Sarah Rose; Deborah Ritchie; Robert S. Sheldon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

903 A randomized clinical trial of fludr

✍ R. Sheldon; C. Morillo; A. Krahn; E. Medina; M. Talajic; T. Kus; M. Lelonek; D. 📂 Article 📅 2011 🏛 Pulsus Group Inc 🌐 English ⚖ 172 KB

Pacemaker therapy for prevention of sync

✍ S.J. Connolly; R. Sheldon; K.E. Thorpe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 33 KB

The North American vasovagal pacemaker s

✍ StuartJ Connolly; Robert Sheldon; RobinS Roberts; Michael Gent 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Lack of efficacy of atenolol for the pre

✍ A.H Madrid; J Ortega; J.G Rebollo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 33 KB

The Childhood Asthma Prevention Study (C

✍ Seema Mihrshahi; Jennifer K Peat; Karen Webb; Euan R Tovey; Guy B Marks; Craig M 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Rationale and design of the Post-MI FREE

✍ Niteesh K. Choudhry; Troyen Brennan; Michele Toscano; Claire Spettell; Robert J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 129 KB